Tenet Healthcare Corp (NYSE: THC) crashed a 52-week low on Friday after reporting a weak Q3 and lowering its outlook for the full financial year.
Tenet to buyback shares
On the plus side, the healthcare services company announced a $1.0 billion share repurchase programme. In the earnings press release, CEO Saum Sutaria said:
Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.
Our business continues to generate strong free cash flow, enabling us to authorise a share repurchase programme that balances our uses of capital with investments to grow the business and debt retirement.
But investors seem to have discounted that authorisation.
The sell-off, though, might have created an attractive opportunity to invest in this stock considering the Wall Street has a consensus “buy” rating on it. The average price target on Tenet Healthcare Corp is $92 that represents more than a 100% upside from here.
Tenet Healthcare Q3 results
- Earned $131 million versus the year-ago $449 million
- Per-share earnings fell sharply from $4.13 to $1.16
- On an adjusted basis, earned $1.44 per share
- Revenue slid 2.0% year-on-year to $4.80 billion
- Consensus was $1.24 a share on $4.81 billion revenue
Tenet Healthcare future outlook
For the full year, Tenet now forecasts $5.88 to $6.42 of adjusted EPS on $19 billion to $19.2 billion in revenue. In comparisons, analysts had called for $6.38 a share and $19.27 billion of revenue.
Its Q4 guidance was also below the Street expectations. CEO Sutaria also said:
During Q3, we worked to continue to recover from our cyberattack and dealt with a very active COVID spike among our employees, but the operating discipline across our business units allowed us to adapt to the environment.
Copy expert traders easily with eToro. Invest in stocks like Tesla & Apple. Instantly trade ETFs like FTSE 100 & S&P 500. Sign-up in minutes.
10/10
68% of retail CFD accounts lose money